Even mild symptoms can be dangerous in high-risk people or those taking new medicines like semaglutide
Their once-a-week administration makes them more convenient and easier to use compared to taking a daily pill or shot of insulin
27, 2024 (HealthDay News) Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers
Novo will, however, keep patent protection for semaglutide in Europe and Japan until 2033, and in the US until 2032
Neuroscience, 285, 281291
They enhance glucose-dependent insulin secretion from pancreatic beta cells, suppress inappropriate glucagon release from alpha cells, and act on the central nervous system to reduce appetite and food intake